20 Executives Selected for Women In Bio’s Second Boardroom Ready Class
Tuesday, August 1, 2017
Preparing Women in Life Sciences for Boards of Directors Roles
25% of Women graduates from First Boardroom Ready Program selected to serve on Boards
August 01, 2017 08:30 ET | Source: Women In Bio BOSTON, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Gender equality momentum continues, as an additional 20 accomplished female life sciences executives will comprise the second cohort of Women In Bio’s (WIB) Boardroom Ready program, the organization announced today.
The women will complete an executive-level board certification program at George Washington University in preparation to serve as corporate Boards of Directors. WIB’s Boardroom Ready selection committee, comprised of six men and women with extensive board experience in the biotechnology and pharma industries, conducted an in-depth review of applications and chose the 20 outstanding candidates most qualified for corporate board service.
“Women In Bio launched the program in June 2016, and we are very pleased with the five successful board placements to date,” said Dawn Hocevar, WIB President. “Although there is good progress, we know WIB and our partners have a long journey ahead to achieve our goal of gender equity on boards and in the C-suite.”
The newly selected 2017 class participants include:
Teresa Bitelli, Senior Vice President - US Oncology, Bristol Myers Squibb
Sophie Chapelle, Managing Director, Golden Seeds
Dominique Côté, Vice President and Head of Global Marketing Excellence, UCB
Daniella Cramp, Global Vice President, Cardio Metabolic Business Unit, Alere Inc.
Rosamond Deegan, CBO and President, Bicycle Therapeutics
Rebecca Frey, Vice President, Operations and Portfolio Management, Alexion Pharmaceuticals
Brenda Furlow, Senior Vice President, Corporate Secretary and General Counsel, Bio-Techne Corporation
Renee Gala, Senior Vice President and Chief Financial Officer, Theravance Biopharma
Nancy Griffin, VP and Head, Alliance Management, Global Business Development & Licensing, Novartis Pharmaceuticals
Jane Gross, CSO, Senior Vice President Research and Development, Aptevo Therapeutics
Angela Justice, Chief Learning Officer, Biogen
Nerissa Kreher, Chief Medical Officer, AVROBIO
Tina Liedtky, Vice President, Global Marketing & Product Development, Cardio Metabolic, Alere, Inc.
Monica Luchi, Chief Medical Officer, EVP Global Clinical Development, Immune Pharmaceuticals
Sandra Orta, SVP Global Marketing, Corp. Strategy & Business Development, Evofem Biosciences
Lauren Sabella, Chief Commercial Officer, Acorda
Natascha Schill, Managing Director, Biogen
Birgit Schoeberl, Head of Discovery and Early Development, SVP Merrimack
Jane Wasman, President, International & General Counsel, Acorda Therapeutics
Jaime Welch, VP Marketing & Communications, OncoGenex Pharmaceuticals, Inc.
“We consistently heard from board members and executives that they couldn’t find qualified women to join their board. The Boardroom Ready program is designed to provide companies with access to vetted, exceptionally qualified executives who are ready for board service,” said Boardroom Ready Co-Chair Carolyn Brougham.
WIB will host an intensive board competency building and certification program at George Washington University this fall to help candidates understand the duties, responsibilities, and commitments related to serving on both public and private boards. The course has been tailored for the Boardroom Ready candidates based on their current skill sets and backgrounds, as well as specific case studies. Course topics include fiduciary responsibility, corporate governance, investor relations, legal liability, corporate strategy, and risk management.
In addition to the board certification class, candidates will be paired with a seasoned board coach, and will participate in networking events designed to facilitate board appointments. With the combination of class completion and the resources provided to the graduates, WIB can achieve its goals to place a majority of Boardroom Ready graduates on Boards, and continue to progress towards equal gender representation on Boards.
LifeSci Advisors, an investor relations consultancy focused in the life sciences sector, is the Founding Sponsor of the Boardroom Ready program, with additional support provided by MassBio and Biogen.
“We could not be more impressed by the extensive knowledge and depth of experience exhibited by both the inaugural and current classes of participants in the Boardroom Ready program,” said Michael Rice, Founding Partner of LifeSci Advisors. “LifeSci is incredibly proud to be sponsoring this program, and we look forward to continuing to help the Boardroom Ready class participants make meaningful connections, with the goal of getting placed on corporate boards.”
The Boardroom Ready training class is held on an annual basis, with applications accepted each spring. If you are aware of available board positions, interested in sponsoring this important program, and/or interested in becoming a mentor to one of the class participants please email firstname.lastname@example.org.
Contact: Stacie D. Byars, National Marketing Director, Women In Bio Mobile: (206) 660-2588 E-mail: email@example.com